The genomic landscape of small intestine neuroendocrine tumors

Journal of Clinical Investigation

Volumn 123, Issue 6, 2013, Pages 2502-2508

  Banck, Michaela S ^a,b   Kanwar, Rahul ^a   Kulkarni, Amit A ^a   Boora, Ganesh K ^a   Metge, Franziska ^a   Kipp, Benjamin R ^c   Zhang, Lizhi ^c   Thorland, Erik C ^c   Minn, Kay T ^a   Tentu, Ramesh ^a   Eckloff, Bruce W ^c   Wieben, Eric D ^c   Wu, Yanhong ^c   Cunningham, Julie M ^c   Nagorney, David M ^c   Gilbert, Judith A ^d   Ames, Matthew M ^d   Beutler, Andreas S ^a,b  

^a MAYO CLINIC ROCHESTER   (United States)

^b MAYO CLINIC CANCER CENTER   (United States)

^c MAYO CLINIC   (United States)

^d MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 2; HEAT SHOCK PROTEIN 90; NUCLEOTIDE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; RAS PROTEIN; SMAD1 PROTEIN; TRANSCRIPTION FACTOR EZH2; VON HIPPEL LINDAU PROTEIN;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA DAMAGE; DNA SEQUENCE; EXOME; GENE AMPLIFICATION; GENE DOSAGE; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; NERVE FIBER; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMALL INTESTINE TUMOR; TUMOR GENE;

BASE SEQUENCE; EXOME; GENES, NEOPLASM; GENOMICS; HUMANS; INTESTINAL NEOPLASMS; MUTATION; NEUROENDOCRINE TUMORS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-AKT; RNA SPLICE SITES; SEQUENCE ANALYSIS, DNA; SIGNAL TRANSDUCTION;

EID: 84878557793     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI67963     Document Type: Article

References (30)

1. Rindi G, et al. Nomenclature and classification of neuroendocrine neoplasms of the digestive system. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, eds. WHO Classification Of Tumours Of The Digestive System. Lyon, France: IARC Press; 2010:13-14.
2. Greenman C, et al. Patterns of somatic mutation in human cancer genomes. Nature. 2007; 446(7132):153-158.
3. Jiao Y, et al. DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science. 2011; 331(6021):1199-1203.
4. Quesada V, et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet. 2012;44(1):47-52.
5. Wang L, et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med. 2011;365(26):2497-2506.
6. Mardis ER, et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med. 2009;361(11):1058-1066.
7. Ellis MJ, et al. Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature. 2012;486(7403):353-360.
8. Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.
9. Barbieri CE, et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat Genet. 2012;44(6):685-689.
10. Stransky N, et al. The mutational landscape of head and neck squamous cell carcinoma. Science. 2011;333(6046):1157-1160.
11. Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330-337.
12. Imielinski M, et al. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell. 2012;150(6):1107-1120.
13. Lonigro RJ, et al. Detection of somatic copy number alterations in cancer using targeted exome capture sequencing. Neoplasia. 2011;13(11):1019-1025.
14. Kulke MH, et al. High-resolution analysis of genetic alterations in small bowel carcinoid tumors reveals areas of recurrent amplification and loss. Genes Chromosomes Cancer. 2008;47(7):591-603.
15. Kim do H, Nagano Y, Choi IS, White JA, Yao JC, Rashid A. Allelic alterations in well-differentiated neuroendocrine tumors (carcinoid tumors) identified by genome-wide single nucleotide polymorphism analysis and comparison with pancreatic endocrine tumors. Genes Chromosomes Cancer. 2008; 47(1):84-92.
16. Tönnies H, et al. Analysis of sporadic neuroendocrine tumours of the enteropancreatic system by comparative genomic hybridisation. Gut. 2001; 48(4):536-541.
17. Andersson E, Swärd C, Stenman G, Ahlman H, Nilsson O. High-resolution genomic profiling reveals gain of chromosome 14 as a predictor of poor outcome in ileal carcinoids. Endocr Relat Cancer. 2009; 16(3):953-966.
18. Cunningham JL, Díaz de Ståhl T, Sjöblom T, Westin G, Dumanski JP, Janson ET. Common pathogenetic mechanism involving human chromosome 18 in familial and sporadic ileal carcinoid tumors. Genes Chromosomes Cancer. 2011;50(2):82-94.
19. Zikusoka MN, Kidd M, Eick G, Latich I, Modlin IM. The molecular genetics of gastroenteropancreatic neuro-endocrine tumors. Cancer. 2005; 104(11):2292-2309.
20. Beroukhim R, et al. The landscape of somatic copynumber alteration across human cancers. Nature. 2010;463(7283):899-905.
21. Gilbert JA, et al. Molecular markers for novel therapies in neuroendocrine (carcinoid) tumors. Endocr Relat Cancer. 2010;17(3):623-636.
22. Kidd M, Schimmack S, Lawrence B, Alaimo D, Modlin IM. EGFR/TGFα and TGFβ/CTGF signaling in neuroendocrine neoplasia: theoretical therapeutic targets. Neuroendocrinology. 2013;97(1):35-44.
23. Wimmel A, Wiedenmann B, Rosewicz S. Autocrine growth inhibition by transforming growth factor beta-1 (TGFβ-1) in human neuroendocrine tumour cells. Gut. 2003;52(9):1308-1316.
24. Kidd M, et al. Small bowel carcinoid (enterochromaffin cell) neoplasia exhibits transforming growth factor-beta1-mediated regulatory abnormalities including up-regulation of C-Myc and MTA1. Cancer. 2007;109(12):2420-2431.
25. Papageorgis P, et al. Smad4 inactivation promotes malignancy and drug resistance of colon cancer. Cancer Res. 2011;71(3):998-1008.
26. Connolly EC, Freimuth J, Akhurst RJ. Complexities of TGF-β targeted cancer therapy. Int J Biol Sci. 2012;8(7):964-978.
27. Gaur P, et al. Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumors. Gastroenterology. 2011; 141(5):1728-1737.
28. Di Florio A, et al. Src kinase activity coordinates cell adhesion and spreading with activation of mammalian target of rapamycin in pancreatic endocrine tumour cells. Endocr Relat Cancer. 2011;18(5):541-554.
29. Lee RS, et al. A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers. J Clin Invest. 2012;122(8):2983-2988.
30. Biankin AV, et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature. 2012;491(7424):399-405.